Molecular design of glucose sensors in glucose-responsive insulin analogues
AssigneeThe Trustees of Indiana University
InventorsMichael A. WEISS, Mark A. JAROSINSKI
Life of this patent
Estimating the term…
Abstract
A two-chain insulin analogue is provided containing (a) a B chain modified by the addition of a C-terminal diol element in combination with (b) a glucose-binding element attached to the A chain at or near its N terminus, optionally linked to a D-amino acid. A “flipped” set of insulin analogues wherein the A chain is modified by addition of an N-terminal diol element whereas the glucose-binding element is attached at or near the C terminus of the B chain is also provided. Compositions comprising such insulin analogues are used in methods of treating a patient with diabetes mellitus.
Claims25
An insulin analogue comprising an insulin A chain and an insulin B chain,
- said insulin A chain comprising either (a) a D-amino acid at position A1, (b) an L- or D-amino acid at A0 or (c) an L- or D amino acid at A−1 to which one or more glucose-binding elements is covalently linked, where residues A0 and A−1 represent optional N-terminal extensions of the A chain;
- and said insulin B chain contains one or more diol groups at or near the C terminus of the insulin B chain, optionally with the proviso that at least one of positions A0 and A1 is present and is a D amino acid.
(canceled)
(canceled)
-21. (canceled)
A method of preparing an analogue by means of trypsin-mediated semi-synthesis comprising (a) introducing an optional A-chain modification within a des-octapeptide[B23-B30] fragment of insulin or an insulin analogue and (b) introducing a diol-containing B-chain modification within a synthetic peptide of length 5-10 amino-acid residues whose N-terminal residue is Glycine and which upon modification contains no tryptic cleavage site.
(canceled)
(canceled)
Dependencies are inferred from the claim text.